Sign inJoin waitlistJoin the waitlist

Jodi Skiles

Clinical Program Director, Pediatric &Amp · Indiana University School of Medicine

Credentials: · · · ·

History

Clinical, Pediatric &amp · Indiana University School of Medicine
Present
Pediatric Stem Cell Transplant &amp Section · Indiana University School of Medicine
Present
Adolescent Young Adult Oncology Program · Indiana University School of Medicine
Present

Pediatric Hematology/Oncology
Indiana University School of Medicine
2008–2011
Pediatrics
Indiana University School of Medicine
2005–2008
Indiana University School of Medicine
2001–2005

Research

Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab
Pediatric Blood & Cancer · 2013 · 243 citations
Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia
Journal of the Peripheral Nervous System · 2015 · 153 citations
Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2023 · 146 citations

Jamie Renbarger
10 papers
Terry Vik
8 papers
April Rahrig
5 papers · 2 as a fellow
Richard Ho
4 papers
Courtney Rowan
3 papers
David Jacobsohn
3 papers
Niketa Shah
3 papers
Rachel Vreeman
3 papers
RH
Raymond Hutchinson
3 papers
Alexander Ngwube
2 papers
Alice Rhoton-Vlasak
2 papers · 2 as a resident
AA
Allistair Abraham
2 papers

Clinical trials

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
Site PI · Recruiting
University of Rochester
2024–2030
Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant
Site PI · Recruiting · Phase 1
Huda Salman
2024–2042
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
Site PI · Recruiting · Phase 2
Pediatric Transplantation & Cellular Therapy Consortium
2018–2026
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
Site PI · Recruiting · Phase 2
New York Blood Center
2012–2030